AI in Healthcare publishes articles, curated news, and a conferences calendar for the people building, regulating, and using AI in clinical settings.
One short email every Monday morning with the week's articles, curated news, and upcoming conferences. No empty mailings — if there's nothing new, we skip the week.
We'll email you a confirmation link before adding you. One-click unsubscribe in every email. Privacy.
Long-form
FDA de novo autonomy carve-outs and the HHS autonomous-agents RFI mark the start of federal rulemaking that will define the vendor economics of the agentic AI category through 2028.
ONC's final enforcement framework for HTI-2 turns the DSI transparency rule into a live operational obligation. Here is what vendors and health systems need to have in place by January 1, 2027.
Ambient AI scaled on primary care. The expansion into oncology, surgery, and cardiology is a different product problem — and it will decide the next phase of vendor positioning.
CMS's Medicare Advantage AI prior-auth final rule, state AG investigations, and commercial-plan rulemaking are converging into a defined accountability architecture that payers must build to.
Asia-Pacific healthcare AI is not waiting for U.S. solutions. It is a collection of fast-moving markets building local capability with government backing.
Whole-slide imaging and AI algorithms for CADe, tumor grading, and mitosis counting are deployed. The next challenge is proving patient outcome impact.